1Fleissig A,Fallowfield LJ,Langridge CI,et al.Post-operative arm morbidity and quality of life.Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer[J].Breast Cancer Res Treat,2006; 95(3):279-293.
2Veronesi U,Paganelli G,Viale G,et al.A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[J].N Engl J Med,2003; 349(6):546-553.
3Julian TB,Krag D,Brown A,et al.Preliminary technical results of NSABP B-32,a randomized phase Ⅲ clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients[J].Breast Cancer Res Treat,2004; 88(Suppl 1):s11-s12.
4Helyer LK,Coburn NG,Law CH,et al.Axillary staging is more accurate today than ever before:no increase in the false negative rate with wide-spread adoption of sentinel node technique[J].Breast Cancer Res Treat,2007; 106(Suppl 1):s127-s128.
5Filippakis GM,Zografos G.Contraindications of sentinel lymph node biopsy:are there any really?[J].World J Surg Oncol,2007; 5(1):10-20.
6Lyman GH,Giuliano AE,Somerfield MR,et al.American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J].J Clin Oncol,2005; 23(30):7703-7720.
7Silverstein MJ,Lagios MD,Recht A,et al.Image-detected breast cancer:state of the art diagnosis and treatment[J].J Am Coll Surg,2005; 201(4):586-597.
8Carlson RW,Anderson BO,Burstein HJ,et al.NCCN breast cancer clinical practice guidelines in oncology.Version 1,2009.Available at:http://www.nccn.org/physician_gls/ PDF/breast.pdf.Accessed January 25,2009.
9Goldhirsch A,Wood WC,Gelber RD,et al.Progress and promise:highlights of the international expert consensus on the primary therapy of early breast cancer 2007[J].Ann Oncol,2007; 18(7):1133-1144.